Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT07589231
Recruiting Not applicable

Effects of Carbon Fiber Insoles on CMJ and Sprint Performance

NCT07589231 · tracked via the Priya Life Science Spain tracker
Sponsor
Benjamín Cuenca Valero
Phase
Not applicable
Started
2025-10-30
Last updated
2026-05-15

Condition(s) studied

HealthySportsmanPreventionPerformanceHealthy Adult ManSports PerformanceAthletic Performance and Injury Risk

Investigational drug(s) / intervention(s)

VKTRY Insoles

VKTRY Insoles: Carbon fiber insoles (VKTRY)

Study summary

This study evaluates the effects of VKTRY carbon fiber insoles on vertical jump and sprint performance in moderately active men. Participants will perform tests with and without insoles, assessing both objective performance and subjective perception using a Likert-type scale.

Eligibility

Sex
MALE
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Men aged 18-30 years * Moderate physical activity (2-4 times/week) * No injuries in the last 6 months Exclusion Criteria: * Use of orthoses or podiatric pathologies * Neurological or cardiovascular disease * Refusal to sign informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Católica de Valencia Valencia Valencia Recruiting

More Benjamín Cuenca Valero trials in Spain

Assessment of Weight-bearing Ankle Range of Motion Using the Ankle Test and Lower Body Test and Its Relationship With Ligamentous Hyperlaxity in Child Basketball Players Aged 8 to 15 Years Recruiting

Other trials for the same condition

Effects of Staged Adapted Inclusions in Infant Cereals on Oral-motors Patterns of 6-24 Month-old Children Recruiting
Prevention of ANxiety and Depression Over Risk Assessment Starting soon
Comparison of the Perception of Non-technical Skills Recruiting
Manual Therapy and Physical-sport Performance Active, not recruiting
Early Diagnosis of Colorectal Cancer Based on a Non-invasive Metabolomics Profile Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07589231 on ClinicalTrials.gov ↗ ← All trials in Spain